Providing patients with focused and personal support at the optimal time points will empower them to successfully use and optimize their V-Go to manage their diabetes and simplify their lives - John Timberlake, President and CEO of Valeritas
NEW YORK (PRWEB) January 15, 2019
Cecelia Health a leading diabetes management technology-enabled personalized coaching company based in New York City, announced today it is partnering with Valeritas, to support the success of V-Go, an innovative wearable insulin delivery device for people living with diabetes who require insulin. Cecelia Health Certified Diabetes Educators (CDEs) will support people living with diabetes with both their initial use of V-Go as well as their ongoing use of V-Go to help them achieve improved results with their diabetes management. V-Go is an insulin delivery option for people with diabetes who require insulin that is worn like a patch and can replace the need to take multiple daily shots.
Managing diabetes is complicated. For many patients, effective diabetes management includes educating and motivating them to take their prescribed therapies, such as V-Go.
Cecelia Health CDEs are diabetes expert clinicians with advanced accreditations who specialize in motivating people living with diabetes on how to self-manage their condition. Cecelia Health leverages its proprietary diabetes care management technology platform to enable CDEs to provide one-on-one coaching support that help patients understand the benefits of V-Go and how to use V-Go following their first prescription and support them to efficiently manage their diabetes through continued use of the V-Go as prescribed. Combining personalized service together with technology enables Cecelia Health to scale the reach of CDEs to efficiently motivate positive behavior change and provide patients living with diabetes access to personalized education and training to foster better diabetes health.
“By partnering with Cecelia Health, and using professional Certified Diabetes Educators (CDEs), we will be able to both enhance and scale the education and support we offer our patients benefiting from V-Go. Cecelia Health CDEs are able to support our mission of providing patients with needed education to initiate and maintain use of V-Go.” Said John Timberlake, President and CEO of Valeritas ”Providing patients with focused and personal support at the optimal time points will empower them to successfully use and optimize their V-Go to manage their diabetes and simplify their lives.”
“Diabetes is a job no one wants”, said David Weingard CEO of Cecelia Health, “Our national team of CDE clinicians scale their reach through the use of our proprietary innovative technology to deliver effective and personalized one-on-one care. It is the personal and expert touch of a CDE that educates, supports and guides people to self-manage their diabetes while also empowering them to take advantage of all available resources so they can succeed in every way possible.”
About Cecelia Health (Formerly Fit4D)
Cecelia Health is on a moonshot mission to transform the lives of people living with diabetes by providing scalable and effective diabetes management programs through an optimized mix of Certified Diabetes Educators (CDEs) and technology to deliver measurable outcomes in an affordable manner. The Cecelia Health clinical team includes CDEs with clinical credentials as nurses, registered dietitians, pharmacists, exercise physiologists, social workers and more, who are all passionate about empowering people with diabetes to live rich, healthy and fulfilling lives. For more information please visit: http://www.ceceliahealth.com
About Valeritas Holdings, Inc.
Valeritas is a commercial-stage medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies. Valeritas’ flagship product, V-Go ® Wearable Insulin Delivery device, is a simple, affordable, all-in-one basal-bolus insulin delivery option for patients with diabetes that is worn like a patch and can eliminate the need for taking multiple daily shots. V-Go administers a continuous preset basal rate of insulin over 24 hours, and it provides discreet on-demand bolus dosing at mealtimes. It is the only basal-bolus insulin delivery device on the market today specifically designed keeping in mind the needs of type 2 diabetes patients. Headquartered in Bridgewater, New Jersey, Valeritas operates its R&D functions in Marlborough, Massachusetts.